IL15 and leukemia: However, the observed toxicity in mice is a subject of debate, as another study found that CD19 CAR-T cells expressing membrane-bound chimeric IL-15 delayed leukemia development, exhibited sustained resistance after tumor clearance, and generated long-lived TSCM cells without any associated toxicity (211).